Cargando…
Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors
To assess the safety and clinical outcomes of multi-probe stereotactic radiofrequency ablation (SRFA) for very large (≥8 cm) primary and metastatic liver tumors with curative treatment intent. A retrospective, single center study carried out between 01.2005 and 06.2018. 34 consecutive patients had a...
Autores principales: | Schullian, Peter, Johnston, Edward W., Putzer, Daniel, Eberle, Gernot, Laimer, Gregor, Bale, Reto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994461/ https://www.ncbi.nlm.nih.gov/pubmed/32005871 http://dx.doi.org/10.1038/s41598-020-58383-y |
Ejemplares similares
-
Reliability of Stereotactic Radiofrequency Ablation (SRFA) for Malignant Liver Tumors: Novice versus Experienced Operators
por: Schullian, Peter, et al.
Publicado: (2023) -
Stereotactic Radiofrequency Ablation of Breast Cancer Liver Metastases: Short- and Long-Term Results with Predicting Factors for Survival
por: Schullian, Peter, et al.
Publicado: (2021) -
Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians
por: Schullian, Peter, et al.
Publicado: (2019) -
Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation
por: Laimer, Gregor, et al.
Publicado: (2020) -
Frequency and risk factors for major complications after stereotactic radiofrequency ablation of liver tumors in 1235 ablation sessions: a 15-year experience
por: Schullian, Peter, et al.
Publicado: (2020)